J&J Health & Wellness Solutions

Johnson & Johnson Health and Wellness Solutions puts behavior science to work in healthcare. We collaborate with health plans, health systems and retailers to deliver behavior change solutions at scale. These solutions are proven to deliver better health outcomes, business performance and patient experience.

Science of behavior change: Our areas of focus

For more than 135 years, Johnson & Johnson has been a leader in groundbreaking research and innovative health solutions. Our Behavior Science team carries on that tradition by helping people live healthier lives through healthier choices. We look at the ecosystem of factors, including well-being, to create solutions purposefully designed to influence health behaviors associated with desired health outcomes, adapted to the needs of individuals.

Two children smiling and running ahead of their family members on a sidewalk

The link between well-being and health behavior

A close up of a woman practicing yoga with her hands clasped together at the center of her chest

Behavior change principles

A female doctor speaking on the phone while examining a white clipboard

Measuring effectiveness of digital health technologies

A close-up of a hand holding a pen and signing documents

Behavior science, data science and technology

A female patient smiling and listening to a male doctor

Healthcare professionals’ influence on patient health engagement

We need to work across the healthcare industry to improve health, create better patient experiences and support those who devote their lives to improving the health of others.

Len Greer

President, Johnson & Johnson Health and Wellness Solutions
Our team of world-class behavior and data scientists is dedicated to making the world a healthier place. Human health behavior is extremely complex, but our rigorous approach takes the guesswork out of behavior change to help people see sustainable results.

Jennifer Turgiss

DrPH, M.S., Vice President, Behavior Science & Advanced Analytics

1 of 2

More from Johnson & Johnson

Health & wellness

Illustration of three human bladders representing bladder cancer

April 30, 2024

5 things we now know about bladder cancer

Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. For Bladder Cancer Awareness Month, learn how Johnson & Johnson is helping to change the treatment landscape.

Innovation

April 29, 2024

What is IL-23?

This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.